The Durable Medicines Company
Medicine can do more.
For most chronic diseases, treatment is a burden. It doesn’t have to be this way.
Kriya is building a new generation of durable medicines designed to be “one-time”– a lasting treatment with one-time administration. By reinventing how these medicines are designed, developed, manufactured, and delivered, we are committed to making durable medicines that can scale to help millions of people around the world.
Kriya was built differently.
Traditional medicines are often developed in piecemeal fashion with processes and systems that are off-the-shelf commodities. Durable medicines require complex engineering and sophisticated infrastructure.
Kriya has built an integrated product engine where research, development, and manufacturing work as one. By incorporating innovations in production into the earliest stages of the drug discovery process, Kriya has assembled one of the world’s most comprehensive structured manufacturing datasets – called HOPSON™. Our engine gets more efficient and intelligent with each turn of the crank.
Durable medicines are the future of medicine. We built a company to deliver that future.
Where science, scale and expertise come together.
Great science isn’t enough. Transformational medicines also require capacity that scales and intelligence that improves with each data point.
Experienced scientists, engineers, and operators sit side by side at our campus in Research Triangle Park, North Carolina, applying the latest suite of artificial intelligence and applied computational tools to extract value from every experiment, manufacturing run, and dataset. We are uniquely positioned to accelerate the delivery of durable medicines from discovery to commercialization – and we are determined to change how chronic diseases are treated.
Built to reach millions.
Kriya is advancing one of the industry’s broadest portfolios of durable medicines, each built with the same principles in mind and engineered on the same system. Every program strengthens the next, creating a flywheel for innovation, scale and patient impact.
Disclaimer
Kriya’s durable medicines are investigational and have not been approved as safe or effective by any regulatory health authority.